Background In this study, we report our experience of cytoreductive surgery plus
hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) in patients with peritoneal …

Background Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal
cancer (CRC) because conventional treatment modalities could not produce significant …

Purpose This study aimed to assess the evaluation of clinical outcomes and consequences
of complications after cytoreductive surgery (CRS) and hyperthermic intraperitoneal …

Background Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC)
improves survival compared with chemotherapy alone in patients with peritoneal …

Introduction Compared with intravenous chemotherapy, cytoreductive surgery (CRS) and
hyperthermic intraperitoneal chemotherapy (HIPEC) have been shown to improve survival in …

Background Peritoneal carcinomatosis (PC) from colorectal cancer is associated with a poor
prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy …

Purpose The prognosis of peritoneal carcinomatosis (PC) from colorectal cancer has been
improved with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy …

Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor
survival outcome. As our understanding of its biology evolved, the paradigm of the …

Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …

Background and Objectives Morbidity after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy (CRS+ HIPEC) for colorectal peritoneal carcinomatosis (PC) …